Journal for ImmunoTherapy of Cancer (Nov 2020)
629 Targeting a shared TP53 neoantigen with bispecific T cell retargeting antibody
- Nickolas Papadopoulos,
- Kenneth Kinzler,
- Drew Pardoll,
- Bert Vogelstein,
- Shibin Zhou,
- Qing Wang,
- Emily Hsiue,
- Katharine Wright,
- Jacqueline Douglass,
- Michael Hwang,
- Brian Mog,
- Alexander Pearlman,
- Annika Schaefer,
- P Aitana Azurmendi,
- Sandra Gabelli
Affiliations
- Nickolas Papadopoulos
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Kenneth Kinzler
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Drew Pardoll
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Bert Vogelstein
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Shibin Zhou
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Qing Wang
- 2Complete Omics Inc., Baltimore, MD, USA
- Emily Hsiue
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Katharine Wright
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Jacqueline Douglass
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Michael Hwang
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Brian Mog
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Alexander Pearlman
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Annika Schaefer
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- P Aitana Azurmendi
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Sandra Gabelli
- 1Johns Hopkins University School of Medicine, Baltimore, MD, USA
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0629
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.